Benitec Biopharma (BNTC) Exchange Rate Effect (2019 - 2025)
Benitec Biopharma's (BNTC) quarterly Exchange Rate Effect came in at -$132000.0 in Q4 2025, down 146.32% year-on-year from $285000.0 in Q4 2024, and down 253.49% quarter-over-quarter from $86000.0 in Q3 2025.
Benitec Biopharma (BNTC) Exchange Rate Effect (2019 - 2025) Analysis & Trends
Benitec Biopharma has disclosed Exchange Rate Effect across 7 years of filings, most recently posting -$132000.0 for Q4 2025.
- Exchange Rate Effect for Q4 2025 came in at -$132000.0, down 146.32% year-over-year; the trailing twelve-month figure through Dec 2025 was -$187000.0 (down 162.33% YoY), and the FY2025 annual result was $49000.0, up 712.5% from the prior year.
- Exchange Rate Effect came in at -$132000.0 for Q4 2025 at Benitec Biopharma, down from $86000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $501000.0 in Q3 2022 to a low of -$277000.0 in Q1 2022.
- The 5-year median for Exchange Rate Effect is $8000.0 (2023), against an average of $35950.0.
- Across the five-year window, Exchange Rate Effect jumped 274.85% in 2024 and slumped 2300.0% in 2025, its largest moves.
- Benitec Biopharma's Exchange Rate Effect stood at -$54000.0 in 2021, then tumbled by 183.33% to -$153000.0 in 2022, then dropped by 6.54% to -$163000.0 in 2023, then surged by 274.85% to $285000.0 in 2024, then tumbled by 146.32% to -$132000.0 in 2025.
- The last three Exchange Rate Effect figures came in at -$132000.0 (Q4 2025), $86000.0 (Q3 2025), and -$120000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 8.68 Mn |
| 10 | Benitec Biopharma | 488.21 Mn | 488.21 Mn | - | -132,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -132,000.00 |
| Dec 31, 2025 | -132,000.00 |
| Sep 30, 2025 | 86,000.00 |
| Sep 30, 2025 | 86,000.00 |
| Jun 30, 2025 | -120,000.00 |
| Jun 30, 2025 | -120,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | -95,000.00 |
| Sep 30, 2024 | -95,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | -163,000.00 |
| Dec 31, 2023 | -163,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Sep 30, 2023 | 45,000.00 |